Compounds having the formula:
1
are disclosed. M
1
and M
2
are the same or different and are transition metal atoms or ions; Z
2
and Z
3
, independently, are the atoms necessary to complete a 3-12 membered heterocyclic ring; Z
1
is an alkylene or arylene group; Ql and Q
2
are the same or different and are electron withdrawing groups; L
1
and L
3
, taken together, represent —O—CR
13
—O—; L
2
and L
4
, taken together, represent —O—CR
14−
—O—; and R
13
and R
14
are the same or different and are selected from the group consisting of alkyl groups and aryl groups or R
13
and R14 represent alkylene or arylene groups that are directly or indirectly bonded to one another. Methods for making such compounds are also disclosed, as are intermediates which can be used in their preparation. Also disclosed are methods for carrying out C—H insertion reactions using bis-transition metal catalysts, such as the above compounds. Procedures for preparing d-threo methylphenidate, tolterodine, CDP-840, nominfensine, and sertraline, are described.
本文披露了具有1式的化合物。其中,M1和M2相同或不同,是过渡
金属原子或离子;Z2和Z3独立地是必要的原子,以完成一个3-12成员的杂环环;Z1是烷基或芳基基团;Q1和Q2相同或不同,是电子提取基团;L1和L3一起表示-O-CR13-O-;
L2和L4一起表示-O-CR14-O-;R13和R14相同或不同,选自由烷基和芳基组或R13和R14表示直接或间接相互连接的烷基或芳基基团。本文还披露了制备这种化合物的方法,以及可用于其制备的中间体。还披露了使用双过渡
金属催化剂(例如上述化合物)进行C-H插入反应的方法。描述了制备d-threo甲基苯
乙胺、
托吡酯、CDP-840、
诺米芬辛和
舍曲林的程序。